Company: OCEA
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-011080
Chunk: 51

Company: Ocean Biomedical, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 51
---
 per share, basic and diluted  
    $(0.09) 
    $0.48 

See accompanying notes to the unaudited condensed consolidated
financial statements

5

OCEAN BIOMEDICAL, INC.

Condensed Consolidated Statements of Stockholders’
Deficit

(in thousands)

(unaudited)

For the Three Months Ended March 31, 2025

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 

    Additional  
       
    Total 

    Common  
    Paid-In  
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances at December 31, 2024 
     35,468,628  
    $   -  
    $107,919  
    $(205,535) 
    $    (97,616)
  
    Net loss 
     -  
     -  
        
     (8,240) 
     (8,240)
  
    Stock-based compensation 
     -  
     -  
     186  
     -  
     186 
  
    Issuance of common stock related to amended and restated convertible note 
     3,844,466  
     -  
     2,614  
     -  
     2,614 
  
    Issuance of common stock for conversion of convertible debt 
     125,964,905  
     -  
     9,900  
     -  
     9,900 
  
    Issuance of common stock for exercise of warrants 
     1,332,806  
     -  
     757  
     -  
     757 
  
    Balances at March 31, 2025 
     166,610,805  
    $-  
    $121,376  
    $(213,775) 
    $(92,399)

For the Three Months Ended March 31, 2024

    Additional  
       
    Total 

    Common  
    Paid-In  
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Capital  
    Deficit